Published in Circ Res on October 15, 1999
Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One (2008) 2.51
Molecular action of methotrexate in inflammatory diseases. Arthritis Res (2002) 2.04
Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer. Clin Cancer Res (2009) 1.66
Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors. Am J Pathol (2002) 1.50
Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life. J Clin Invest (2010) 1.49
Host A(2B) adenosine receptors promote carcinoma growth. Neoplasia (2008) 1.43
The A2b adenosine receptor protects against vascular injury. Proc Natl Acad Sci U S A (2008) 1.39
The resurgence of A2B adenosine receptor signaling. Biochim Biophys Acta (2010) 1.23
Adenosine receptor agonists for promotion of dermal wound healing. Biochem Pharmacol (2008) 1.06
Regulation of sFlt-1 and VEGF secretion by adenosine under hypoxic conditions in rat placental villous explants. Am J Physiol Regul Integr Comp Physiol (2010) 1.00
Role of adenosine A(2B) receptors in inflammation. Adv Pharmacol (2011) 0.94
Adenosine receptors in wound healing, fibrosis and angiogenesis. Handb Exp Pharmacol (2009) 0.94
Role of A2B adenosine receptors in regulation of paracrine functions of stem cell antigen 1-positive cardiac stromal cells. J Pharmacol Exp Ther (2012) 0.92
Adenosine receptors and fibrosis: a translational review. F1000 Biol Rep (2011) 0.87
Impaired adenosine-mediated angiogenesis in preeclampsia: potential implications for fetal programming. Front Pharmacol (2014) 0.86
Adenosine infusion increases plasma levels of VEGF in humans. BMC Physiol (2005) 0.85
Adenosine receptors: expression, function and regulation. Int J Mol Sci (2014) 0.84
Adenosine in inflammatory joint diseases. Purinergic Signal (2007) 0.84
Genetic inactivation of the adenosine A2A receptor attenuates pathologic but not developmental angiogenesis in the mouse retina. Invest Ophthalmol Vis Sci (2010) 0.83
Role of JunB in adenosine A2B receptor-mediated vascular endothelial growth factor production. Mol Pharmacol (2013) 0.82
Activation of adenosine receptor A2A increases HSC proliferation and inhibits death and senescence by down-regulation of p53 and Rb. Front Pharmacol (2014) 0.81
Potential role of A2B adenosine receptors on proliferation/migration of fetal endothelium derived from preeclamptic pregnancies. Biomed Res Int (2014) 0.79
Novel selective antagonist radioligands for the pharmacological study of A(2B) adenosine receptors. Purinergic Signal (2006) 0.78
Adenosine A2B receptors induce proliferation, invasion and activation of cAMP response element binding protein (CREB) in trophoblast cells. BMC Pregnancy Childbirth (2014) 0.78
Variants of the adenosine A(2A) receptor gene are protective against proliferative diabetic retinopathy in patients with type 1 diabetes. Ophthalmic Res (2010) 0.77
The Adenosinergic System in Diabetic Retinopathy. J Diabetes Res (2016) 0.75
Adenosine A1 Receptors Selectively Modulate Oxygen-Induced Retinopathy at the Hyperoxic and Hypoxic Phases by Distinct Cellular Mechanisms. Invest Ophthalmol Vis Sci (2015) 0.75
Adenosine A2A receptor regulates expression of vascular endothelial growth factor in feto-placental endothelium from normal and late-onset pre-eclamptic pregnancies. Purinergic Signal (2016) 0.75
Geometric and electronic structure/function correlations in non-heme iron enzymes. Chem Rev (2000) 5.44
The diagnosis and treatment of baroreflex failure. N Engl J Med (1993) 3.45
A potent pressor response elicited by drinking water. Lancet (1999) 3.02
Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med (1997) 2.88
The neuropathic postural tachycardia syndrome. N Engl J Med (2000) 2.86
Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med (2000) 2.53
Adenosine A2B receptors. Pharmacol Rev (1997) 2.38
Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine. Heart (2006) 2.33
Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia. Circulation (1983) 2.05
Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J Clin Invest (1995) 2.01
Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol (1997) 1.88
Isolated atrial myocytes: adenosine and acetylcholine increase potassium conductance. Am J Physiol (1983) 1.86
Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia. Circulation (1997) 1.73
Bradycardia after heart transplantation: reversal with theophylline. J Am Coll Cardiol (1996) 1.67
Differential effects of adenosine and nitroglycerin on the action potentials of large and small coronary arteries. Circ Res (1979) 1.65
Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy. J Neuropathol Exp Neurol (2000) 1.63
Oxford house: a review of research and implications for substance abuse recovery and community research. J Drug Educ (2001) 1.61
Hypovolemia in syncope and orthostatic intolerance role of the renin-angiotensin system. Am J Med (1997) 1.57
A2A-adenosine receptor reserve for coronary vasodilation. Circulation (1998) 1.55
The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study. Diabetes Care (2000) 1.54
The pressor response to water drinking in humans : a sympathetic reflex? Circulation (2000) 1.52
Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes. FASEB J (1995) 1.49
Interaction of carbon dioxide and sympathetic nervous system activity in the regulation of cerebral perfusion in humans. Hypertension (2000) 1.45
Theophylline for the treatment of atrioventricular block after myocardial infarction. Ann Intern Med (1995) 1.45
Genetic polymorphisms of adrenergic receptors. Clin Auton Res (2001) 1.45
Effects of dipyridamole on coronary collateralization and myocardial perfusion in patients with ischaemic cardiomyopathy. Eur Heart J (2001) 1.45
Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias. J Am Coll Cardiol (1985) 1.45
Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity. Circulation (1986) 1.41
The A2A adenosine receptor mediates coronary vasodilation. J Pharmacol Exp Ther (1998) 1.40
Cardiac electrophysiology of adenosine. Basic and clinical concepts. Circulation (1991) 1.38
Actions of adenosine and isoproterenol on isolated mammalian ventricular myocytes. Circ Res (1983) 1.37
Vestibular control of sympathetic activity. An otolith-sympathetic reflex in humans. Exp Brain Res (2002) 1.36
Evolution of river dolphins. Proc Biol Sci (2001) 1.36
Oral yohimbine in human autonomic failure. Neurology (1987) 1.31
Sympathetically mediated hypertension in autonomic failure. Circulation (2000) 1.29
Adenosine A2B receptors: a novel therapeutic target in asthma? Trends Pharmacol Sci (1998) 1.28
Natriuretic and diuretic actions of a highly selective adenosine A1 receptor antagonist. J Am Soc Nephrol (1999) 1.28
Role of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinase kinase in adenosine A2B receptor-mediated interleukin-8 production in human mast cells. Mol Pharmacol (1999) 1.27
Atrioventricular conduction disturbances during hypoxia. Possible role of adenosine in rabbit and guinea pig heart. Circ Res (1980) 1.23
Malignant vagotonia due to selective baroreflex failure. Hypertension (1997) 1.20
Contrasting actions of pressor agents in severe autonomic failure. Am J Med (1998) 1.20
Proliferation, migration, and ERK activation in human retinal endothelial cells through A(2B) adenosine receptor stimulation. Invest Ophthalmol Vis Sci (2001) 1.20
Dopamine beta-hydroxylase deficiency. A genetic disorder of cardiovascular regulation. Hypertension (1991) 1.19
The hypertension of autonomic failure and its treatment. Hypertension (1997) 1.18
Ionic basis for the antagonism between adenosine and isoproterenol on isolated mammalian ventricular myocytes. Circ Res (1984) 1.18
Psychiatric profile and attention deficits in postural tachycardia syndrome. J Neurol Neurosurg Psychiatry (2008) 1.18
Extracellular action of adenosine and the antagonism by aminophylline on the atrioventricular conduction of isolated perfused guinea pig and rat hearts. Circ Res (1982) 1.15
Single exposures to antiproliferatives: long-term effects on ocular fibroblast wound-healing behavior. Invest Ophthalmol Vis Sci (1997) 1.13
Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists. J Pharmacol Exp Ther (2001) 1.12
Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites. Mol Cell Biochem (2008) 1.12
Management of chronic orthostatic hypotension. Am J Med (1986) 1.12
Inflammatory agents regulate in vivo expression of fractalkine in endothelial cells of the rat heart. J Leukoc Biol (1999) 1.10
Adenosine A(2A) receptors mediate coronary microvascular dilation to adenosine: role of nitric oxide and ATP-sensitive potassium channels. J Pharmacol Exp Ther (1999) 1.09
Hemodynamic and humoral effects of caffeine in autonomic failure. Therapeutic implications for postprandial hypotension. N Engl J Med (1985) 1.09
Inverse agonists and neutral antagonists of recombinant human A1 adenosine receptors stably expressed in Chinese hamster ovary cells. Mol Pharmacol (1998) 1.06
Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and acute cutaneous wounds of healthy humans. Cell Tissue Res (1997) 1.05
Adenosine-sensitive afterdepolarizations and triggered activity in guinea pig ventricular myocytes. Circ Res (1992) 1.05
Effects of adenosine on atrial refractoriness and arrhythmias. Cardiovasc Res (1994) 1.05
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor. Bioorg Med Chem Lett (2000) 1.04
Long-term type 1 diabetes influences haematopoietic stem cells by reducing vascular repair potential and increasing inflammatory monocyte generation in a murine model. Diabetologia (2012) 1.03
Correlation of sinus slowing and hyperpolarization caused by adenosine in sinus node. Pflugers Arch (1985) 1.03
Paroxysmal supraventricular tachycardia with Wenckebach block: evidence for reentry within the upper portion of the atrioventricular node. J Am Coll Cardiol (1984) 1.03
Abnormal norepinephrine clearance and adrenergic receptor sensitivity in idiopathic orthostatic intolerance. Circulation (1999) 1.02
Pharmacological characterization of adenosine A2B receptors: studies in human mast cells co-expressing A2A and A2B adenosine receptor subtypes. Biochem Pharmacol (1998) 1.01
Patterns of plasma levels of catechols in neurogenic orthostatic hypotension. Ann Neurol (1989) 1.01
Effect of adenosine and adenosine-5'-triphosphate on atrioventricular conduction in patients. J Am Coll Cardiol (1985) 1.01
Proliferating endothelial cell-specific expression of IGF-I receptor ribozyme inhibits retinal neovascularization. Gene Ther (2006) 1.01
Adenosine A(2A) and A(2B) receptors in cultured human and porcine coronary artery endothelial cells. Am J Physiol Heart Circ Physiol (2000) 1.01
NO modulates norepinephrine release in human skeletal muscle: implications for neural preconditioning. Am J Physiol Regul Integr Comp Physiol (2001) 1.01
Dromotropic effects of adenosine and adenosine antagonists in the treatment of cardiac arrhythmias involving the atrioventricular node. Circulation (1984) 1.00
Potential role of fomites in the vehicular transmission of human astroviruses. Appl Environ Microbiol (2001) 1.00
Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease. Neurology (1999) 1.00
Adenosine inhibits the rise in intracellular calcium and platelet aggregation produced by thrombin: evidence that both effects are coupled to adenylate cyclase. Mol Pharmacol (1990) 1.00
Inhibition of human mast cell activation with the novel selective adenosine A(2B) receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)(2). Biochem Pharmacol (2001) 1.00
Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure. J Am Soc Nephrol (1999) 0.99
Robust anti-arrhythmic efficacy of verapamil and flunarizine against dofetilide-induced TdP arrhythmias is based upon a shared and a different mode of action. Br J Pharmacol (2010) 0.99
Idiopathic orthostatic intolerance and postural tachycardia syndromes. Am J Med Sci (1999) 0.99
Expression of IGF-I, IGF-I receptor and IGF binding proteins-1, -2, -3, -4 and -5 in human atherectomy specimens. Regul Pept (1996) 0.98
Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. A potential treatment for restenosis? Circulation (1994) 0.98
Positive modulation of intracellular Ca2+ levels by adenosine A2b receptors, prostacyclin, and prostaglandin E1 via a cholera toxin-sensitive mechanism in human erythroleukemia cells. Mol Pharmacol (1994) 0.98
Characterization of adenosine receptors in human erythroleukemia cells and platelets: further evidence for heterogeneity of adenosine A2 receptor subtypes. Mol Pharmacol (1993) 0.98
Inhibition of late sodium current to reduce electrical and mechanical dysfunction of ischaemic myocardium. Br J Pharmacol (2007) 0.98
Direct vasodilator effect of hyperventilation-induced hypocarbia in autonomic failure patients. Am J Med Sci (1991) 0.98
Matrix metalloproteinase expression in human retinal microvascular cells. Diabetes (1998) 0.97
Evidence of spare A1-adenosine receptors in guinea pig atrioventricular node. Am J Physiol (1992) 0.97
Cardiac glycoside stimulation of inward Ca++ current in vascular smooth muscle of canine coronary artery. J Pharmacol Exp Ther (1979) 0.97
Cellular basis for the negative dromotropic effect of adenosine on rabbit single atrioventricular nodal cells. Circ Res (1996) 0.96
Effect of salt supplementation on amphotericin B nephrotoxicity. Kidney Int (1991) 0.96